Abstract
An amendment to the original 2017 study published in Scientific Reports has been issued to address a technical error in the description of the microfluidic device's geometric architecture. This correction clarifies the specific channel dimensions required to ensure proper droplet capture for high-throughput drug screening.
Introduction
In 2017, a study was published detailing a droplet microfluidic platform designed for screening drugs against cancer cell lines and primary tumors. The efficacy of such platforms relies heavily on the precise control of fluid dynamics to ensure that droplets containing biological samples are correctly routed into capture wells. Following publication, a labeling error was identified in the Results section concerning the geometric ratios of the device's channels. This correction provides the accurate specifications necessary for the reproducibility of the screening platform.
The Role of Hydrodynamic Resistance
The movement of droplets within a microfluidic network is governed by the path of least hydrodynamic resistance. In the architecture described, droplets must transition from a main channel into specific capture wells. This process is mediated by two key components: the "neck" (the entrance to the well) and the "bypass" (the alternative path around the well).
If the resistance in the bypass channel is too low relative to the neck, droplets will fail to enter the wells. Conversely, excessive resistance can lead to system clogs. The original text contained a reversal in the description of these dimensions, which could lead to device failure if followed by researchers attempting to replicate the platform.
Corrected Geometric Specifications
The authors conducted a design-optimization study to identify the configuration that most effectively favors fluid flow into the capture wells. Three specific width configurations (bypass width / neck width) were evaluated:
- 75 μm / 100 μm
- 100 μm / 100 μm
- 100 μm / 150 μm
The correction clarifies that the optimal configuration is a 3:4 width ratio of the bypass channel to the neck channel. Specifically, the bypass channel must be 75 μm wide while the neck channel is 100 μm wide. This measurement refers to the bypass-to-neck ratio, not the neck-to-bypass ratio as previously stated.
Key Results and Validation
The quantitative validation of the platform confirms that the 75 μm (bypass) / 100 μm (neck) design is the only configuration among those tested that successfully creates the pressure differential required to "push" droplets into the screening wells.
The authors emphasize that reversing this ratio—making the neck narrower than the bypass—would result in droplets bypassing the capture wells entirely, rendering the drug screening platform ineffective. Visual evidence of the functional 3:4 ratio is documented in the original publication's Supplementary Movie 2, which demonstrates the intended fluid behavior and droplet capture.
Conclusion
This technical amendment ensures that the physical parameters of the microfluidic capture system are accurately documented. For the scientific community utilizing droplet microfluidics for oncology research, these precise measurements are critical for the successful implementation and adaptation of high-throughput drug-screening assays.
Summary updated